Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (550)	5/13/2000 1:04:00 AM
From: dalroi	Respond to of 743

chirodoc cist is an entry in celltech cheers stefaan

To: chirodoc who wrote (550)	5/13/2000 4:40:00 PM
From: RWReeves	Read Replies (1) \| Respond to of 743

<reeves, do you like CIST?> Like Stefaan said, for the CLL. I like CLL quite a lot and even ponied up some bucks to buy it when it was 50 so buying it for 30's (current price) seems like a better deal. Fabulous moderate-risk pipeline and IP IMO. Buying it via the CIST discount is even better: Message 13371076 Before the deal MM asked me what I thought of CIST and I think I said something like it looked like it had nice IP but no cash and hence crater-bait. As long as the deal goes through, I'm in. Peter warned me about do it yourself arbitrage (CEGE valuation) but do I listen? Current valuation discounts the deal with CLL, but volume has been pretty low. I've heard nothing to suggest the deal is off, but I haven't got my shiny new CLL shares either yet. RWR